BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22155455)

  • 21. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma.
    Józkowicz A; Huk I; Nigisch A; Cisowski J; Weigel G; Dulak J
    Acta Biochim Pol; 2003; 50(3):677-89. PubMed ID: 14515149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
    Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative regulation of urokinase-type plasminogen activator production through FGF-2-mediated activation of phosphoinositide 3-kinase.
    Mochizuki Y; Tsuda S; Kanetake H; Kanda S
    Oncogene; 2002 Oct; 21(46):7027-33. PubMed ID: 12370824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
    Nonaka M; Tazuma S; Hyogo H; Kanno K; Chayama K
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e198-206. PubMed ID: 17868335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.
    Burgermeister E; Chuderland D; Hanoch T; Meyer M; Liscovitch M; Seger R
    Mol Cell Biol; 2007 Feb; 27(3):803-17. PubMed ID: 17101779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents Ox-LDL-induced macrophage apoptosis.
    Paland N; Aharoni S; Fuhrman B
    Atherosclerosis; 2013 Nov; 231(1):29-38. PubMed ID: 24125407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines.
    Raghu H; Lakka SS; Gondi CS; Mohanam S; Dinh DH; Gujrati M; Rao JS
    PLoS One; 2010 Aug; 5(8):e12458. PubMed ID: 20805979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and AMPK-dependent lipid lowering effect in hepatocytes.
    Ho FM; Liao YH; Yang AJ; Lee Chao PD; Hou YC; Huang CT; Lin SR; Lee KR; Huang KC; Lin WW
    J Ethnopharmacol; 2012 Jun; 142(1):175-87. PubMed ID: 22543166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system.
    Sawai H; Liu J; Reber HA; Hines OJ; Eibl G
    Mol Cancer Res; 2006 Mar; 4(3):159-67. PubMed ID: 16547153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner.
    Fuhrman B; Nitzan O; Karry R; Volkova N; Dumler I; Aviram M
    Atherosclerosis; 2007 Dec; 195(2):e108-16. PubMed ID: 17681345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice.
    Rozenberg O; Shih DM; Aviram M
    Atherosclerosis; 2005 Jul; 181(1):9-18. PubMed ID: 15939049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allyl isothiocyanate as a potential inducer of paraoxonase-1--studies in cultured hepatocytes and in mice.
    Schrader C; Graeser AC; Huebbe P; Wagner AE; Rimbach G
    IUBMB Life; 2012 Feb; 64(2):162-8. PubMed ID: 22131196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.
    Arii K; Suehiro T; Ota K; Ikeda Y; Kumon Y; Osaki F; Inoue M; Inada S; Ogami N; Takata H; Hashimoto K; Terada Y
    Atherosclerosis; 2009 Feb; 202(2):439-45. PubMed ID: 18572174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urokinase-type plasminogen activator deficiency has little effect on seizure susceptibility and acquired epilepsy phenotype but reduces spontaneous exploration in mice.
    Rantala J; Kemppainen S; Ndode-Ekane XE; Lahtinen L; Bolkvadze T; Gurevicius K; Tanila H; Pitkänen A
    Epilepsy Behav; 2015 Jan; 42():117-28. PubMed ID: 25506794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urokinase-plasminogen activator protects periodontal ligament fibroblast from oxidative induced-apoptosis and DNA damage.
    Ahmad Akhoundi MS; Rokn A; Bagheri R; Momeni N; Hodjat M
    J Periodontal Res; 2018 Oct; 53(5):861-869. PubMed ID: 29920670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraoxonase 1 (PON1) reduces macrophage inflammatory responses.
    Aharoni S; Aviram M; Fuhrman B
    Atherosclerosis; 2013 Jun; 228(2):353-61. PubMed ID: 23582715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction.
    Hohensinner PJ; Takacs N; Kaun C; Thaler B; Krychtiuk KA; Pfaffenberger S; Aliabadi A; Zuckermann A; Huber K; Wojta J
    Apoptosis; 2017 Aug; 22(8):1048-1055. PubMed ID: 28643198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.